Jacquet JM - Search Results

1

Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial.

Espinoza F, Tregnaghi M, Gentile A, Abarca K, Casellas J, Collard A, Lefevre I, Jacquet JM. Espinoza F, et al. Among authors: jacquet jm. BMC Infect Dis. 2010 Oct 15;10:297. doi: 10.1186/1471-2334-10-297. BMC Infect Dis. 2010. PMID: 20950456 Free PMC article. Clinical Trial.

2

The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule.

Chatterjee S, Rego SJ, D'Souza F, Bhatia BD, Collard A, Datta SK, Jacquet JM. Chatterjee S, et al. Among authors: jacquet jm. BMC Infect Dis. 2010 Oct 15;10:298. doi: 10.1186/1471-2334-10-298. BMC Infect Dis. 2010. PMID: 20950457 Free PMC article. Clinical Trial.

3

Booster vaccination after neonatal priming with acellular pertussis vaccine.

Knuf M, Schmitt HJ, Jacquet JM, Collard A, Kieninger D, Meyer CU, Siegrist CA, Zepp F. Knuf M, et al. Among authors: jacquet jm. J Pediatr. 2010 Apr;156(4):675-8. doi: 10.1016/j.jpeds.2009.12.019. J Pediatr. 2010. PMID: 20303444 Clinical Trial.

4

Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.

Tejedor JC, Moro M, Ruiz-Contreras J, Castro J, Gómez-Campderá JA, Navarro ML, Merino JM, Martín-Ancel A, Roca J, García-del-Río M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Boceta R, García-Corbeira P, Jacquet JM, Collard A, Schuerman L; Spanish DTaP-HBV-IPV-097 Study Group. Tejedor JC, et al. Among authors: jacquet jm. Pediatr Infect Dis J. 2006 Aug;25(8):713-20. doi: 10.1097/01.inf.0000227725.61495.c4. Pediatr Infect Dis J. 2006. PMID: 16874171 Clinical Trial.

5

Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine coadministered with a Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months.

Tejedor JC, Moro M, Ruiz-Contreras J, Castro J, Gómez-Campderá JA, Navarro ML, Merino JM, Martín-Ancel A, Roca J, García-Del-Rí M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Boceta R, García-Corbeira P, Collard A, Boutriau D, Schuerman L, Jacquet JM; Spanish DTPa-HBV-IPV-097 Study Group. Tejedor JC, et al. Among authors: jacquet jm. Pediatr Infect Dis J. 2007 Jan;26(1):1-7. doi: 10.1097/01.inf.0000247070.60063.09. Pediatr Infect Dis J. 2007. PMID: 17195697 Clinical Trial.

6

Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of life.

Steiner M, Ramakrishnan G, Gartner B, Van Der Meeren O, Jacquet JM, Schuster V. Steiner M, et al. Among authors: jacquet jm. BMC Infect Dis. 2010 Jan 15;10:9. doi: 10.1186/1471-2334-10-9. BMC Infect Dis. 2010. PMID: 20078876 Free PMC article.

7

Antibody persistence after primary vaccination with a hexavalent DTPa-HBV-IPV/HiB vaccine coadministered with a meningococcal C-CRM197 vaccine and response to a DTPa-IPV/HiB booster at 18 months of age.

Tejedor JC, Omeñaca F, García-Sicilia J, Esporrín C, Molina V, Marés J, Muro M, Sanjuan P, Méndez M, Teixidor R, Enrubia M, García-Corbeira P, Boceta R, Jacquet JM, Schuerman L; Spanish DTPa-IPV/Hib-049 Study Group. Tejedor JC, et al. Among authors: jacquet jm. Pediatr Infect Dis J. 2006 Oct;25(10):943-5. doi: 10.1097/01.inf.0000237917.60734.05. Pediatr Infect Dis J. 2006. PMID: 17006294

8

Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study.

Van Damme P, Moiseeva A, Marichev I, Kervyn AD, Booy R, Kuriyakose S, Brockway A, Ng SP, Leyssen M, Jacquet JM. Van Damme P, et al. Among authors: jacquet jm. BMC Infect Dis. 2010 Dec 20;10:357. doi: 10.1186/1471-2334-10-357. BMC Infect Dis. 2010. PMID: 21171982 Free PMC article. Clinical Trial.

9

A fourth dose of DTPa-IPV vaccine given to 4-6 year old children in Italy and Sweden following primary vaccination at 3, 5 and 11-12 months of age.

Nilsson L, Faldella G, Jacquet JM, Storsaeter J, Silfverdal SA, Ekholm L. Nilsson L, et al. Among authors: jacquet jm. Scand J Infect Dis. 2005;37(3):221-9. doi: 10.1080/00365540410020884. Scand J Infect Dis. 2005. PMID: 15849057 Clinical Trial.

10

Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants.

Vázquez L, Garcia F, Rüttimann R, Coconier G, Jacquet JM, Schuerman L. Vázquez L, et al. Among authors: jacquet jm. Acta Paediatr. 2008 Sep;97(9):1243-9. doi: 10.1111/j.1651-2227.2008.00884.x. Epub 2008 May 16. Acta Paediatr. 2008. PMID: 18489623 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters